Sign in

NCT00748254Recruiting

Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

Source: ClinicalTrials.gov · Last updated 23 Jan 2026

Brief summary (registry, in English)

The purpose of this feasibility study is to determine if a new emerging technology called photoacoustic tomography (PAT) can be adapted for use in humans for the detection of chronic rheumatoid arthritis.

Status (registry)
Recruiting
Study type
Observational
Enrollment
113 (estimated)
First submitted
4 Sept 2008
Start date
1 Dec 2011
Primary completion date
Jan 2027
Lead sponsor
University of Michigan
NCT number
NCT00748254

What you commit to

  • Study type: Observational
  • Planned participants: 113
  • From 1 Dec 2011 to the primary completion date, Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who have had a contrast enhanced (with gadolinium) MRA (magnetic resonance angiography)/ or MRI within the last 3 months. (Contrast is a medication injected into a vein during a imaging examination that helps produce clearer images/pictures).

Other illness

  • Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.

Lab values

  • Patients with impaired renal function cannot participate in this study such as elevate creatinine clearance, patients on kidney dialysis etc.

Other

  • Pregnant patients.
  • Patients who is claustrophobic.
  • Patients with shock hypotension or unstable low blood pressure.
  • Patients with Rhabdomyolysis.

Who the study is looking for

  • Men and women 18 years of age or older can participate in this study.
  • Patients can participate in this study if they have had rheumatoid arthritis for more than 2 years and their rheumatologist has referred them to this study.
  • Patients can participate as a healthy volunteer with a known history of rheumatoid arthritis.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Universtity of Michigan Health System
Coordinator of this site? Confirm its status
Ann ArborUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.